# FDA Inspection 932717 - Carter BloodCare - Longview - June 17, 2015

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-longview/3cd4f1d0-a666-4895-b8bc-aa98f28bae55
Source feed: FDA_Inspections

> FDA Inspection 932717 for Carter BloodCare - Longview on June 17, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 932717
- Company Name: Carter BloodCare - Longview
- Inspection Date: 2015-06-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262070 - 2025-02-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-longview/9c051c1a-c8ee-45bd-aecb-7c89c255e842)
- [FDA Inspection 1262070 - 2025-02-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-longview/533779c0-a382-46f4-a554-025431ddbbc1)
- [FDA Inspection 1097760 - 2019-06-05](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-longview/ac91b2ef-a2ac-4695-a58b-71e835e2df1e)
- [FDA Inspection 1017197 - 2017-06-23](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-longview/0f187322-bc86-47cc-8ada-ef14f3ba7797)
- [FDA Inspection 821700 - 2013-03-05](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-longview/2058ab34-ad2b-4be8-a07f-446974eee84b)

Company: https://www.keypedia.com/companies/carter-bloodcare-longview/4ba0e530-bd97-4236-99fd-e836f706c4ca

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d